Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Berthold F, Sahin K, Hero B et al (1997) The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 33:2092–2097
2. Schwab M, Shimada H, Joshi V et al (1999) Neuroblastic tumours of adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. International Agency for Cancer Research, Lyon
3. Schwab M, Westermann F, Hero B et al (2003) Neuroblastoma: biology, and molecular and chromosomal pathology. Lancet Oncol 4:472–480
4. Shimada H, Ambros IM, Dehner LP et al (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86:349–363
5. Westermann F, Henrich K-O, Wei JS et al (2007) High SKp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Clin Cancer Res 13:4695–4696